Jupiter, Florida, USA – BioTools Inc. (BTI) announced today that it has entered into a cooperative agreement with Chiral Technologies Inc., West Chester, PA, the leader in enantioselective chromatography. The cooperative agreement will bring to our customers the most comprehensive coverage of chirality-related services and technologies ranging from small scale and preparative chromatography to absolute configuration of chiral compounds. The combination of services from two leaders in the field of chirality will greatly improve efficiency and understanding in a range of research areas such as drug discovery, drug development and industrial process.

BioTools innovation and expertise in the field of Vibrational Optical Activity (VOA) have shaped the way chiroptical spectroscopy is used. The company is world renowned for involvement of its advanced VOA instruments such as its ChiralIR-2XTM and ChiralRaman-2XTM in ground breaking applications from determination of absolute configuration of chiral molecules and conformation of biomolecules to formulation of biopharmaceuticals.

“Entering into this collaborative alliance with Chiral Technologies will provide researchers with unique blend of services, instruments, and technologies to advance the understanding that chiral based structures play in biological and chemical processes. It is the combined knowledge and experience of our scientists, along with leading techniques that provides a formidable force to effectively help researchers” said Dr. Rina Dukor, President of BioTools.

“We are delighted to announce this alliance with such an innovative and customer focused company. Combining our expertise in enantioselective chromatography and VCD technology will truly provide a more effective and novel toolbox to enhance R&D work of our customers” commented Dr. Elena Eksteen, Sr. Manager, Business Development & Planning of Chiral Technologies.

About BioTools

BioTools is a recognized established leader in providing advanced chiroptical instrumentation and services to pharmaceutical companies and academia serving critical areas of biopharmaceutical and chiral drugs research. Its unique products are used for molecular structure characterization from basic research to formulated finished products. Founded in

2000, BioTools has R&D, sales, customer support, contract research lab and manufacturing facilities in Jupiter, Florida, and a division, BioTools Europe, headquartered in the United Kingdom, as well a partnership with the Ghent University and the University of Antwerp in the recently commissioned European Centre for Chirality (EC2) (www.chiralitycentre.eu).